The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $21.36

Today's change-0.16 -0.74%
Updated September 21 4:15 PM EDT. Delayed by at least 15 minutes.
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $21.36

Today's change-0.16 -0.74%
Updated September 21 4:15 PM EDT. Delayed by at least 15 minutes.

Spectrum Pharmaceuticals Inc down (U.S.)$0.16

Spectrum Pharmaceuticals Inc closed lower Friday, dropping (U.S.)$0.16 or 0.74% to (U.S.)$21.36. Over the last five days, shares have gained 9.09% and 12.72% year to date. Shares have outperformed the S&P 500 by 100.65% during the last year.

Key company metrics

  • Open(U.S.) $21.50
  • Previous close(U.S.) $21.52
  • High(U.S.) $21.80
  • Low(U.S.) $21.10
  • Bid / Ask(U.S.) $21.36 / (U.S.) $24.35
  • YTD % change+12.72%
  • Volume3,193,441
  • Average volume (10-day)1,617,076
  • Average volume (1-month)1,592,689
  • Average volume (3-month)1,531,999
  • 52-week range(U.S.) $9.03 to (U.S.) $25.29
  • Beta1.84
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.16
Updated September 21 4:15 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2018Q1/2018Q4/2017Q3/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201806/30/2018Mar 31, 201803/31/2018Dec 31, 201712/31/2017Sep 30, 201709/30/2017
Revenue24302936
Total other revenue--------
Total revenue24302936
Gross profit18241724
Total cost of revenue771112
Total operating expense58567052
Selling / general / administrative23243019
Research & development21182214
Depreciation / amortization7777
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-34-25-42-15
Interest income (expense), net non-operating-1-1-1-2
Gain (loss) on sale of assets--------
Other--------
Income before tax14-16-44-20
Income after tax14-1610-19
Income tax, total00-54-1
Net income14-16-29-19
Total adjustments to net income--------
Net income before extra. items14-1610-19
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items14-1610-19
Inc. avail. to common incl. extra. items14-16-29-19
Diluted net income14-16-29-19
Dilution adjustment--------
Diluted weighted average shares11310110083
Diluted EPS excluding extraordinary itemsvalue per share0.12-0.160.10-0.22
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.12-0.160.10-0.22